AI assistant
INSMED Inc — Director's Dealing 2024
Sep 16, 2024
30150_dirs_2024-09-16_41fce92b-cca5-4408-afd3-135a5c072974.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-09-12
Reporting Person: Flammer Martina M.D. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-12 | Common Stock | M | 635 | $34.03 | Acquired | 106769 | Direct |
| 2024-09-12 | Common Stock | S | 635 | $74.92 | Disposed | 106134 | Direct |
| 2024-09-13 | Common Stock | M | 26969 | $34.03 | Acquired | 133103 | Direct |
| 2024-09-13 | Common Stock | S | 26969 | $74.90 | Disposed | 106134 | Direct |
| 2024-09-16 | Common Stock | M | 13436 | $34.03 | Acquired | 119570 | Direct |
| 2024-09-16 | Common Stock | S | 13436 | $74.92 | Disposed | 106134 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | Stock Option (right to buy) | $34.03 | M | 635 | Disposed | 2031-01-07 | Common Stock (635) | Direct |
| 2024-09-13 | Stock Option (right to buy) | $34.03 | M | 26969 | Disposed | 2031-01-07 | Common Stock (26969) | Direct |
| 2024-09-16 | Stock Option (right to buy) | $34.03 | M | 13436 | Disposed | 2031-01-07 | Common Stock (13436) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 635 shares sold at prices ranging from $74.90 to $74.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.